Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Open Forum Infectious Diseases|July 2, 2025
Implementation of an Online Drug-Drug Interaction Screener for the STRIVE Ensitrelvir Trial for COVID-19Joshua P Havens, Nayon Kang, Lucy Chung, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 26, 2013
Prehypertension, hypertension, and the risk of acute myocardial infarction in HIV-infected and -uninfected veteransKaku A Armah, Chung-Chou H Chang, Jason V Baker, et al.
JCI Insight|June 5, 2025
Impact of the IL-15 superagonist N-803 on lymphatic reservoirs of HIVJoshua Rhein, Jeffrey G Chipman, Gregory J Beilman, et al.
Biomed Research International|February 18, 2015
CD8+ T-cells count in acute myocardial infarction in HIV disease in a predominantly male cohortOluwatosin A Badejo, Chung-Chou Chang, Kaku A So-Armah, et al.
Journal of the American Heart Association|October 18, 2014
HIV infection and cardiovascular disease in womenJulie A Womack, Chung-Chou H Chang, Kaku A So-Armah, et al.
Plos Medicine|November 29, 2017
Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: A case studyNathan W Cummins, Stacey Rizza, Mark R Litzow, et al.
AIDS (London, England)|May 31, 2024
MAVMET trial: maraviroc and/or metformin for metabolic dysfunction associated fatty liver disease in adults with suppressed HIVLeanne McCabe, James E Burns, Arash Latifoltojar, et al.
Clinical Trials (London, England)|October 11, 2021
Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3)Daniel D Murray, Abdel G Babiker, Jason V Baker, et al.
Medrxiv : the Preprint Server for Health Sciences|November 20, 2020
Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3)Daniel D Murray, Abdel G Babiker, Jason V Baker, et al.
The Lancet. Microbe|May 30, 2024
Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort studyTomas O Jensen, Thomas A Murray, Greg A Grandits, et al.
Pageof 11